ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 5 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in ProQR Therapeutics N.V. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −5 vs. Q2 2023
- Shares held
- 18.7M
- −2.42M (−11.4%) vs. Q2 2023
- Total value
- $24.3M
- −$9.91M (−28.9%) vs. Q2 2023
- New holders
- 4
- 8 more added
- Sold out
- 9
- 10 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $6.95M | 2.07% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $4.71M | 0.01% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,980,016 | $3.87M | 0.13% | 00.0% | Unchanged |
| M28 Capital Management LP | 1,910,600 | $2.48M | 2.85% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 940,582 | $1.22M | 0.38% | 00.0% | Unchanged |
| Macquarie Group Ltd | 620,000 | $806.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 472,625 | $614.4K | 0.23% | 00.0% | Unchanged |
| Millennium Management LLC | 420,045 | $546.1K | 0.00% | −191,616−31.3% | Reduced |
| Monaco Asset Management SAM | 377,517 | $490.8K | 0.25% | +140,000+58.9% | Added |
| Morgan Stanley | 342,958 | $445.8K | 0.00% | −152,558−30.8% | Reduced |
| Two Sigma Advisers, LP | 228,200 | $296.7K | 0.00% | −233,000−50.5% | Reduced |
| UBS Oconnor LLC | 189,328 | $246.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 180,744 | $235.0K | 0.00% | −307,100−63.0% | Reduced |
| Franklin Street Advisors Inc | 150,000 | $195.0K | 0.02% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 147,505 | $191.8K | 0.00% | −32,892−18.2% | Reduced |
| Squarepoint Ops LLC | 132,378 | $172.1K | 0.00% | −1,764−1.3% | Reduced |
| Bank of America Corp | 108,338 | $140.8K | 0.00% | −46,148−29.9% | Reduced |
| Boothbay Fund Management, LLC | 95,745 | $124.5K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 74,084 | $96.0K | 0.01% | +30,248+69.0% | Added |
| Marshall Wace, LLP | 57,717 | $75.0K | 0.00% | −251,742−81.3% | Reduced |
| Susquehanna International Group, LLP | 40,610 | $52.8K | 0.00% | +40,610 | New |
| Geode Capital Management, LLC | 36,293 | $47.2K | 0.00% | 00.0% | Unchanged |
| JustInvest LLC | 21,429 | $27.9K | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 20,822 | $27.1K | 0.00% | +1,700+8.9% | Added |
| Resources Investment Advisors, LLC. | 19,525 | $25.4K | 0.00% | +4,225+27.6% | Added |
| Advisor Group Holdings, Inc. | 19,461 | $25.3K | 0.00% | −1,665−7.9% | Reduced |
| Mariner, LLC | 18,334 | $23.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,420 | $22.6K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 14,689 | $19.0K | 0.00% | +8,159+124.9% | Added |
| Atom Investors LP | 13,107 | $17.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,996 | $14.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,044 | $13.1K | 0.00% | +5,363+114.6% | Added |
| Truist Financial Corp | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Vontobel Holding Ltd. | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 9,766 | $12.7K | 0.00% | +5,874+150.9% | Added |
| BNP Paribas Arbitrage, SA | 6,701 | $8.71K | 0.00% | −3,226−32.5% | Reduced |
| Lazard Asset Management LLC | 6,214 | $7.00K | 0.00% | +302+5.1% | Added |
| BlackRock Inc. | 3,945 | $5.13K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 4,600 | $5.00K | 0.00% | 00.0% | Unchanged |
| Flaharty Asset Management, LLC | 2,000 | $2.60K | 0.00% | +2,000 | New |
| PFS Partners, LLC | 1,000 | $1.30K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 1,000 | $1.30K | 0.00% | +1,000 | New |
| Qube Research & Technologies Ltd | 33 | $43 | 0.00% | +33 | New |
| Royal Bank of Canada | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −653,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −385,208−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −200,499−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −116,792−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −23,160−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −21,494−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −20,550−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,405−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |